CYLD deletion triggers nuclear factor-κB-signaling and increases cell death resistance in murine hepatocytes

Toni Urbanik1, Bruno Christian Koehler1, Laura Wolpert1

  • 1Toni Urbanik, Bruno Christian Koehler, Laura Wolpert, Christin Elßner, Anna-Lena Scherr, Nicole Kautz, Stefan Welte, Dirk Jäger, Henning Schulze-Bergkamen, National Center for Tumor Diseases, Department of Medical Oncology, University Clinic of Heidelberg, 69120 Heidelberg, Baden-Wuerrtemberg, Germany.

Abstract

Insights

CYLD deficiency protects against liver injury by reducing hepatocyte apoptosis. This occurs through enhanced NF-κB signaling, which increases anti-apoptotic protein expression, making hepatocytes less sensitive to death receptor-mediated cell death.

Area of Science:

  • Hepatology and Immunology
  • Molecular Biology
  • Cell Death Research

Background:

  • Receptor-mediated apoptosis plays a critical role in liver injury.
  • The CYLD (CYLD Lysine 63 Deubiquitinase) gene's function in hepatocyte apoptosis is not fully understood.
  • Understanding CYLD's role is crucial for developing therapeutic strategies against acute liver injury.

Purpose of the Study:

  • To investigate the role of CYLD in receptor-mediated apoptosis of murine hepatocytes.
  • To analyze the impact of CYLD deficiency on acute liver injury models.

Main Methods:

  • Utilized CYLD knockout (CYLD(-/-)) and wild-type (WT) mice in CD95- (Jo2) and tumor necrosis factor-α (TNF-α) [D-GalN/lipopolysaccharide (LPS)] induced liver injury models.
  • Assessed liver injury via serum transaminases (ALT, AST) and histological analysis.
  • Quantified apoptosis using cleaved PARP staining, Western blotting for activated caspases, and MTT assays on primary hepatocytes.

Main Results:

  • CYLD(-/-) mice exhibited significantly reduced apoptosis sensitivity in both liver injury models, with lower ALT and AST levels compared to WT mice.
  • CYLD deficiency led to increased anti-apoptotic nuclear factor-kappa B (NF-κB) signaling in hepatocytes.
  • Isolated CYLD(-/-) primary murine hepatocytes (PMH) showed increased expression of anti-apoptotic proteins (Bcl-2, XIAP, cIAP1/2, survivin, c-FLIP) and were less sensitive to TNF-α and CD95-ligand induced cell death.

Conclusions:

  • CYLD acts as a key regulator of apoptotic cell death in murine hepatocytes.
  • CYLD controls NF-κB-dependent anti-apoptotic signaling pathways.
  • CYLD deficiency confers protection against acute liver injury by modulating hepatocyte apoptosis.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.9K
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
7
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
24